| VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) | Phase 3 | Viking Therapeutics, Inc. | 2 mi |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | Phase 3 | Boehringer Ingelheim | 2 mi |
| A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting | — | Bayer | 2 mi |
| The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) | Phase 3 | Eli Lilly and Company | 2 mi |
| Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist | Phase 2 | AstraZeneca | 2 mi |
| A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation | Phase 1/2 | Sernova Corp | 2 mi |
| Orthotic Treatment of Diabetic Foot Ulcers | N/A | VA Office of Research and Development | 2 mi |
| ECHO Diabetes FQHC | — | University of Florida | 2 mi |
| Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs | N/A | California Polytechnic State University-San Luis Obispo | 2 mi |
| Transformative Research in Diabetic Nephropathy | — | University of Pennsylvania | 2 mi |
| Rare and Atypical Diabetes Network | — | University of South Florida | 2 mi |
| Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers | N/A | Piomic Medical | 2 mi |
| Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome | — | Royal Devon and Exeter NHS Foundation Trust | 2 mi |
| CBTi for the Treatment of Insomnia in Type 1 Diabetes | Early 1 | University of Illinois at Chicago | 2 mi |
| GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes | N/A | Medtronic Diabetes | 2 mi |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort | Phase 1 | AstraZeneca | 2 mi |
| Circadian Mechanisms, Glucose, and CV Risks in T1D | N/A | University of Illinois at Chicago | 2 mi |
| Diabetes Toolkit at Discharge | N/A | Northwestern University | 2 mi |
| MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors | N/A | Clinical Nutrition Research Center, Illinois Institute of Technology | 2 mi |
| Fenofibrate for Prevention of DR Worsening | Phase 3 | Jaeb Center for Health Research | 2 mi |
| Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC) | Phase 4 | Cellution Biologics | 2 mi |
| A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers | N/A | Ann & Robert H Lurie Children's Hospital of Chicago | 2 mi |
| My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes | N/A | University of Illinois at Chicago | 2 mi |
| Improvement of Hyperglycemia/Diabetes in Patients to Improve Safety | — | Northwestern University | 2 mi |
| A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus | Phase 1/2 | Otsuka Pharmaceutical Factory, Inc. | 2 mi |
| Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE) | N/A | University of Illinois at Chicago | 2 mi |
| Diabetic Neuropathy in Spinal Cord Stimulator Patients | — | University of Chicago | 2 mi |
| Islet Transplantation in Patients With "Brittle" Type I Diabetes | N/A | University of Chicago | 2 mi |
| A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin | Phase 3 | Eli Lilly and Company | 2 mi |
| Islet Transplantation in Type 1 Diabetic Kidney Allograft | Phase 2 | University of Chicago | 2 mi |
| Type 1 Diabetes and Obstructive Sleep Apnea | N/A | University of Chicago | 2 mi |
| Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D) | Phase 1/2 | University of Chicago | 2 mi |
| Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes | Phase 3 | Kailera | 2 mi |
| TArgeting Type 1 Diabetes Using POLyamines (TADPOL) | Phase 2 | Emily K. Sims | 2 mi |
| Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease | Phase 3 | Prokidney | 2 mi |
| Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics | — | Milton S. Hershey Medical Center | 2 mi |
| Effect of Continuing Versus Holding Metformin During Hospitalizations. | Phase 4 | University of Illinois at Chicago | 2 mi |
| Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease | Phase 2 | Regeneron Pharmaceuticals | 2 mi |
| Diabetes RElated to Acute Pancreatitis and Its Mechanisms | — | Milton S. Hershey Medical Center | 2 mi |
| A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes | Phase 3 | Vertex Pharmaceuticals Incorporated | 2 mi |
| Role of Adiposomes in Endothelial Dysfunction | N/A | University of Illinois at Chicago | 2 mi |
| A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes | Phase 3 | Novo Nordisk A/S | 2 mi |
| Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) | Phase 2 | Sparrow Pharmaceuticals | 2 mi |
| A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) | Phase 3 | Eli Lilly and Company | 2 mi |
| Achieving Routine Intervention and Screening for Emotional Health | N/A | University of Chicago | 2 mi |
| Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes | N/A | Northwestern University | 2 mi |
| Sleep, Diabetic Retinopathy and Melatonin | Phase 2 | University of Illinois at Chicago | 2 mi |
| Registry for Stage 2 Type 1 Diabetes | — | Sanofi | 2 mi |
| A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | Phase 2 | Children's Oncology Group | 2 mi |
| Enhancing Diabetes Care: Exposome &Amp; Sensors | — | University of Illinois at Chicago | 2 mi |
| Mechanisms of Prediabetic States in Sleep Apnea | N/A | University of Chicago | 2 mi |
| Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress | — | University of Illinois at Chicago | 2 mi |
| Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial | N/A | Sonavex, Inc. | 2 mi |
| Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals | N/A | Clinical Nutrition Research Center, Illinois Institute of Technology | 2 mi |
| A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events | N/A | Cleerly, Inc. | 2 mi |
| Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease | Phase 3 | Alessandro Doria | 2 mi |
| Vasoactive Drugs in Intensive Care Unit | Phase 4 | University of Chicago | 2 mi |
| Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes | Phase 4 | VA Office of Research and Development | 2 mi |
| Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant | — | University of Chicago | 2 mi |
| Effectiveness of Remote Foot Temperature Monitoring | N/A | VA Office of Research and Development | 11 mi |
| Empagliflozin Treatment in Kidney Transplant Recipients | Phase 4 | VA Office of Research and Development | 11 mi |
| RCT Glargine vs NPH for Treatment of DM in Pregnancy | Phase 3 | Loyola University | 11 mi |
| A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers | N/A | Integra LifeSciences Corporation | 12 mi |
| Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes | N/A | Endogenex, Inc. | 12 mi |
| A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease | Phase 2 | Novo Nordisk A/S | 12 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes | Phase 3 | Eli Lilly and Company | 12 mi |
| FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS) | Phase 2 | Sanofi | 12 mi |
| A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes | Phase 2 | Hoffmann-La Roche | 13 mi |
| Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus | Phase 2 | Hanmi Pharmaceutical Company Limited | 13 mi |
| A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01 | Phase 2 | Vantage Biosciences Ltd | 16 mi |
| Study of WAL0921 in Patients With Glomerular Kidney Diseases | Phase 2 | Walden Biosciences | 17 mi |
| Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes | N/A | Nanjing Nutrabuilding Bio-tech Co., Ltd. | 19 mi |
| Dietary Supplementation on Body Fat Composition | N/A | Brightseed | 19 mi |
| A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight | Phase 3 | Eli Lilly and Company | 23 mi |
| Effects of Walking in Greenspace and the Built Environment in Adults With Prediabetes: A Randomized Crossover Trial | N/A | University of Minnesota | 27 mi |
| A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight Without Type 2 Diabetes | Phase 3 | Hoffmann-La Roche | 37 mi |